search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Partner News


Mark Johnston, Managing Director, Glasgow Airport with Charlie Miller, Regional Sales Manager, Alexander Dennis Limited


Cyber security lab launches at Glasgow Caledonian University


A STATE-of-the-art lab that allows students to experience and combat ‘real-life’ cyber-attacks has been unveiled at Glasgow Caledonian University (GCU). The launch of the Cyber Lab housing the Security Operations Centre (SOC) marks a sequence of new partnerships to ensure that the next generation of security experts have the skills and experience required in today’s evolving cyber-threat landscape. By partnering with data centre, cloud and managed security services provider Proact, and security intelligence company LogRhythm, the University has introduced the latest software and services so students can gain critical training by mimicking a real-world environment. The SOC offers a ‘safe’ environment for students to tackle cyber-attacks of all shapes and sizes. The opening coincided with the


Scottish Government’s initiatives to drive digital transformation, where businesses of all kinds are encouraged to leverage digital services. Access to security skills will play a key part in every company’s innovation plans.


Green buses for airport


GLASGOW has become the first UK airport to introduce a fleet of zero-emission electric buses to its car park operation. The three-strong fleet of all-electric battery buses, which were built in Scotland by Alexander Dennis Limited (ADL), will replace the current diesel fleet used to shuttle passengers between the terminal and the airport’s long-stay car park. This is the first time the


BYD ADL Enviro200EV model has been operated anywhere in Scotland and its introduction at Glasgow Airport was made possible thanks to a £450,000 Green Bus Fund support grant from Transport Scotland. The launch of the airport’s


new electric fleet coincided with Scotland’s Climate Week 2019 during which events were organised in schools, colleges and workplaces across the


country to encourage people to take action to reduce greenhouse gas emissions. The introduction of


the new full-electric bus fleet is one of a number of projects introduced to help reduce Glasgow Airport’s carbon footprint. Earlier this year, the airport invested £200,000 to deploy eight of petrol/electric plug-in hybrid Mitsubishi Outlander PHEV 4x4 vehicles across its airfield operations.


New Glasgow Cancer Tests for research and clinical trials The Glasgow Cancer Tests can be


THE Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground-breaking new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered. The Glasgow Cancer Tests are a suite of


affordable solid tumour and blood cancer tests, developed specifically to enable patients to benefit from real-world precision medicine-based cancer treatments. The Glasgow Cancer Tests are designed


to be used in routine healthcare, such as the NHS, around the world, to enable doctors to offer the latest treatments and trials to cancer patients. These tests will also help scientists discover what makes cancer resistant to chemotherapy drugs, as well as provide data that will aid the development of new treatments. The Glasgow Cancer Tests are being


Wayne Barraclough, Chief Security Officer, Proact and Jackie Riley, Head of Department for Cyber Security and Networks, GCU


16 www.glasgowchamberofcommerce.com


evaluated by NHS labs in England and Scotland. The tests are also being used in the University of Glasgow-led Precision- Panc clinical trials programme for patients with pancreatic cancer.


used for any cancer and will provide more information to understand what is driving a patient’s cancer, and therefore which drugs would be best to trial for that patient. This will give patients better


access to new treatments and trials based on the genetic makeup of their disease.


The Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground- breaking new cancer test for research and clinical trials


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48